Macquarie Group’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$403K Sell
2,658
-48,926
-95% -$7.42M ﹤0.01% 1485
2025
Q1
$7.76M Buy
51,584
+9,923
+24% +$1.49M 0.01% 862
2024
Q4
$7.33M Buy
41,661
+38,250
+1,121% +$6.73M 0.01% 866
2024
Q3
$672K Buy
3,411
+1,100
+48% +$217K ﹤0.01% 1438
2024
Q2
$477K Sell
2,311
-32,324
-93% -$6.68M ﹤0.01% 1469
2024
Q1
$9.38M Buy
34,635
+6,135
+22% +$1.66M 0.01% 842
2023
Q4
$6.74M Buy
28,500
+13,214
+86% +$3.12M 0.01% 904
2023
Q3
$3M Sell
15,286
-595
-4% -$117K ﹤0.01% 1054
2023
Q2
$3.34M Sell
15,881
-5,555
-26% -$1.17M ﹤0.01% 1026
2023
Q1
$4.33M Buy
21,436
+14,508
+209% +$2.93M 0.01% 960
2022
Q4
$1.51M Sell
6,928
-3,652
-35% -$796K ﹤0.01% 1295
2022
Q3
$2.08M Buy
10,580
+4,853
+85% +$955K ﹤0.01% 1212
2022
Q2
$1.23M Buy
5,727
+4,513
+372% +$966K ﹤0.01% 1438
2022
Q1
$345 Sell
1,214
-96
-7% -$27 ﹤0.01% 1725
2021
Q4
$493K Sell
1,310
-748
-36% -$281K ﹤0.01% 1653
2021
Q3
$849K Sell
2,058
-339
-14% -$140K ﹤0.01% 1621
2021
Q2
$887K Buy
2,397
+617
+35% +$228K ﹤0.01% 1620
2021
Q1
$515K Sell
1,780
-495
-22% -$143K ﹤0.01% 1529
2020
Q4
$568K Buy
2,275
+158
+7% +$39.4K ﹤0.01% 1431
2020
Q3
$479K Buy
2,117
+100
+5% +$22.6K ﹤0.01% 1412
2020
Q2
$352K Buy
2,017
+698
+53% +$122K ﹤0.01% 1423
2020
Q1
$166K Hold
1,319
﹤0.01% 1500
2019
Q4
$201K Sell
1,319
-1,740
-57% -$265K ﹤0.01% 1605
2019
Q3
$405K Sell
3,059
-726
-19% -$96.1K ﹤0.01% 1409
2019
Q2
$538K Buy
3,785
+2,617
+224% +$372K ﹤0.01% 1339
2019
Q1
$170K Buy
1,168
+1,068
+1,068% +$155K ﹤0.01% 1476
2018
Q4
$11K Buy
+100
New +$11K ﹤0.01% 1904
2018
Q3
Sell
-400
Closed -$45K 2173
2018
Q2
$45K Buy
+400
New +$45K ﹤0.01% 1962